advertisement

Topcon

George R 11

Showing records 1 to 11 | Display all abstracts from George R

100399 Incidence, risk factors, treatment and outcome of ocular hypertension following intravitreal steroid injections: A comparative study
Badrinarayanan L
Ophthalmologica 2022; 0:
100663 Elucidating the Therapeutic Potential of Cell-Penetrating Peptides in Human Tenon Fibroblast Cells
Chatterjee A
ACS omega 2022; 7: 16536-16546
100399 Incidence, risk factors, treatment and outcome of ocular hypertension following intravitreal steroid injections: A comparative study
Rishi P
Ophthalmologica 2022; 0:
100663 Elucidating the Therapeutic Potential of Cell-Penetrating Peptides in Human Tenon Fibroblast Cells
Ansar S
ACS omega 2022; 7: 16536-16546
100399 Incidence, risk factors, treatment and outcome of ocular hypertension following intravitreal steroid injections: A comparative study
George R
Ophthalmologica 2022; 0:
100663 Elucidating the Therapeutic Potential of Cell-Penetrating Peptides in Human Tenon Fibroblast Cells
Gopal D
ACS omega 2022; 7: 16536-16546
100399 Incidence, risk factors, treatment and outcome of ocular hypertension following intravitreal steroid injections: A comparative study
Isaac N
Ophthalmologica 2022; 0:
100663 Elucidating the Therapeutic Potential of Cell-Penetrating Peptides in Human Tenon Fibroblast Cells
Vetrivel U
ACS omega 2022; 7: 16536-16546
100399 Incidence, risk factors, treatment and outcome of ocular hypertension following intravitreal steroid injections: A comparative study
Rishi E
Ophthalmologica 2022; 0:
100663 Elucidating the Therapeutic Potential of Cell-Penetrating Peptides in Human Tenon Fibroblast Cells
George R; Narayanan J
ACS omega 2022; 7: 16536-16546
100399 Incidence, risk factors, treatment and outcome of ocular hypertension following intravitreal steroid injections: A comparative study

Ophthalmologica 2022; 0:

Issue 23-1

Change Issue


advertisement

Nidek